Reuters probe spot­lights a con­flict of in­ter­est be­tween biotech in­vestor F-Prime and gi­ant Fi­deli­ty

Reuters has done an in-depth spot­light of F-Prime Cap­i­tal Part­ners, a promi­nent biotech ven­ture out­fit owned by the bil­lion­aire John­son fam­i­ly, which al­so found­ed and man­ages the mam­moth mu­tu­al fund Fi­deli­ty In­vest­ments. The news ser­vice con­cludes that F-Prime’s role in a long line­up of biotech com­pa­nies blocked Fi­deli­ty’s par­tic­i­pa­tion in some lu­cra­tive deals, while leav­ing the mu­tu­al fund to play a valu­able role bol­ster­ing the stock F-Prime was able to grab at a bar­gain price.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.